However, in our two-sample MR analysis, the effect estimate for WFDC1 on bladder cancer risk was positive (approximately β = 0.328), implying that genetically higher WFDC1 levels were associated with increased risk of bladder cancer - a result seemingly at odds with its classical tumor-suppressive function. Here, WFDC1 is linked to urinary bladder carcinoma.